Clinical Trial Update: Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation

View source ↗

Summary

A completed clinical trial evaluating morbidity related to secondary hyperparathyroidism in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Snippet

Sponsor: Skane University Hospital | Conditions: Secondary Hyperparathyroidism, Disorder Related to Renal Transplantation | Status: COMPLETED